Common gut bacteria can fuel the growth of prostate cancers and allow them to evade the effects of treatment, a new study finds. Scientists revealed how gut bacteria contribute to the progression of advanced prostate cancers and their resistance to hormone therapy — by providing an alternative source of growth-promoting androgens, or male hormones. Hormone… Read More »
[unable to retrieve full-text content]WEDNESDAY, Sept. 29, 2021 — A pair of experimental tests could help doctors detect colon or prostate cancer with just a sample of blood or saliva. One test examines a person’s blood for four biomarkers linked to inflammation. In a small study, it… Drugs.com – Daily MedNews
FDA Approves Pylarify (piflufolastat F 18) PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer May 27, 2021 — FDA has approved Pylarify (piflufolastat F 18) – a drug for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer. With the approval of Pylarify, certain men with prostate… Read More »
SUNDAY, Sept. 6, 2020 — About 1 in 9 men will be diagnosed with prostate cancer, but experts say early detection can be a lifesaver. “Prostate cancer that is detected early, typically while it is still within the prostate gland, has a better chance of being successfully treated,” explained Dr. Alexander Kutikov, chief of the… Read More »
Population studies Overall, population studies suggest that green tea may help protect against prostate cancer in Asian populations. The duration of intervention was between 6 months [ 13 ] and 1 year [ 25, 26 ], with varying formulations of isoflavones derived from soy [ 13, 25 ] and red clover. Added text about a… Read More »
In June, the US Food and Drug Administration (FDA) launched an accelerated review of a promising new drug for advanced prostate cancer. Called relugolix, it suppresses testosterone and other hormones that speed the cancer’s growth. If approved, this new type of hormonal therapy is expected to set a new standard of care for the disease.… Read More »